These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8697044)

  • 1. Biological actions of drugs affecting serotonin and eating.
    Garattini S
    Obes Res; 1995 Nov; 3 Suppl 4():463S-470S. PubMed ID: 8697044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
    Johnson GJ; Leis LA; Dunlop PC; Weir EK
    J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability.
    Curzon G; Gibson EL; Oluyomi AO
    Trends Pharmacol Sci; 1997 Jan; 18(1):21-5. PubMed ID: 9114726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system.
    Garattini S; Mennini T; Bendotti C; Invernizzi R; Samanin R
    Appetite; 1986; 7 Suppl():15-38. PubMed ID: 2427023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system.
    Garattini S; Bizzi A; Codegoni AM; Caccia S; Mennini T
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):160S-166S. PubMed ID: 1728827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
    Vickers SP; Dourish CT; Kennett GA
    Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anorectic effect of dehydroepiandrosterone and d-Fenfluramine on the obese Zucker rat.
    Gillen G; Porter JR; Svec F
    Physiol Behav; 1999 Aug; 67(2):173-9. PubMed ID: 10477047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin releasing agents. Neurochemical, therapeutic and adverse effects.
    Rothman RB; Baumann MH
    Pharmacol Biochem Behav; 2002 Apr; 71(4):825-36. PubMed ID: 11888573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of the anorectic actions of 5-HTP and fenfluramine.
    Fletcher PJ; Burton MJ
    Psychopharmacology (Berl); 1986; 89(2):216-20. PubMed ID: 3088639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the pharmacology of serotoninergic appetite-suppressive drugs.
    Garattini S
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S41-8. PubMed ID: 1338385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotonergic mechanisms.
    Mennini T; Garattini S; Caccia S
    Psychopharmacology (Berl); 1985; 85(1):111-4. PubMed ID: 2984709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal models.
    Jagroop IA; Mikhailidis DP
    Platelets; 2000 May; 11(3):161-5. PubMed ID: 10938892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions.
    Javed A; Van De Kar LD; Gray TS
    Brain Res; 1997 Nov; 774(1-2):94-105. PubMed ID: 9452197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary sucrose on hippocampal serotonin release: a microdialysis study in the freely-moving rat.
    Smolders I; Loo JV; Sarre S; Ebinger G; Michotte Y
    Br J Nutr; 2001 Aug; 86(2):151-5. PubMed ID: 11502227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.
    Borroni E; Ceci A; Garattini S; Mennini T
    J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain serotonin neurotoxicity and fenfluramine and dexfenfluramine.
    Lipetz PD
    JAMA; 1997 Dec 24-31; 278(24):2141; author reply 2142. PubMed ID: 9417000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.